High dose methylprednisolone induces FcγRI on granulocytes in MS-patients

Journal of Neuroimmunology

Volumn 167, Issue 1-2, 2005, Pages 138-142

  Torkildsen, O ^a   Vedeler, C A ^a   Ulvestad, E ^a   Aarseth, J H ^a   Nyland, H I ^a   Myhr, K M ^a  

^a HAUKELAND UNIVERSITY HOSPITAL   (Norway)

Author keywords

Fc R; Multiple sclerosis; Prednisolone

Indexed keywords

BIOLOGICAL MARKER; FC GAMMA RECEPTOR I; FC GAMMA RECEPTOR III; FC RECEPTOR; METHYLPREDNISOLONE; RECEPTOR SUBUNIT; UNCLASSIFIED DRUG;

ADULT; ANTIGEN ANTIBODY COMPLEX; ARTICLE; CELLULAR DISTRIBUTION; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE MARKER; DOSE RESPONSE; DRUG MECHANISM; DRUG MEGADOSE; FEMALE; GRANULOCYTE; HUMAN; HUMAN CELL; IMMUNOPHARMACOLOGY; MALE; MONOCYTE; MULTIPLE SCLEROSIS; PHARMACODYNAMICS; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN INDUCTION; PROTEIN LOCALIZATION; RECEPTOR DENSITY;

ADULT; ANTI-INFLAMMATORY AGENTS; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; FLOW CYTOMETRY; GRANULOCYTES; HUMANS; MALE; METHYLPREDNISOLONE; MIDDLE AGED; MONOCYTES; MULTIPLE SCLEROSIS; RECEPTORS, IGG; STATISTICS, NONPARAMETRIC; TIME FACTORS;

EID: 24144453179     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jneuroim.2005.06.009     Document Type: Article

References (32)

1. N. Auphan, J.A. DiDonato, C. Rosette, A. Helmberg, and M. Karin Immunosuppression by glucocorticoids: inhibition of NF-kappa activity through induction of I kappa B synthesis Science 270 1995 286 290
2. O. Ayanlar-Batuman, A.P. Ferrero, A. Diaz, and S.A. Jimenez Regulation of transforming growth factor-beta 1 gene expression by glucocorticoids in normal human T lymphocytes J. Clin. Invest. 88 1991 1574 1580
3. T. Berger, P. Rubner, F. Schautzer, and R. Egg Antimyelin antibodies as a predictor of clinically definite multiple sclerosis after a first demyelinating event New Engl. J. Med. 349 2003 139 145
4. D.T. Boumpas, E.D. Anastassiou, S.A. Older, G.C. Tsokos, D.L. Nelson, and J.E. Balow Dexamethasone inhibits human interleukin 2 but not interleukin 2 receptor gene expression in vitro at the level of nuclear transcription J. Clin. Invest. 87 1991 1739 1747
5. G.R. Crabtree, A. Muck, and K.A. Smith Glucocorticoids inhibit expression of Fc receptors on the human granulocytic cell line HL-60 Nature 279 1979 338 339
6. A.D. Crockard, M.T. Treacy, A.G. Droogan, and S.A. Hawkins CD4 subsets (CD45RA/RO) exhibit differences in proliferative responses, IL-2 and gamma-interferon production during intravenous methylprednisolone treatment of multiple sclerosis J. Neurol. 243 1996 475 481
7. B.N. Cronstein, S.C. Kimmel, R.I. Levin, F. Martinuiuk, and G. Weissmann A mechanism for the antiinflammatory effect of corticosteroids: the glucocorticoid receptor regulates leukocyte adhesion to endothelial cells and expression of endothelial-leukocyte adhesion molecule 1 Proc. Natl. Acad. Sci. U. S. A. 89 1992 9991 9995
8. M.K. Dasgupta, K.G. Warren, K.V. Johny, and J.B. Dossetor Circulating immune complexes in multiple sclerosis: relation with disease activity Neurology 32 1982 1000 1004
9. M.T. Girard, S. Hjaltdottir, A.N. Fejes-Toth, and P.M. Guyre Glucocorticoids enhance the γ-interferon augmentation of human monocyte immunoglobulin G Fc receptor expression J. Immunol. 138 1987 3235 3241
10. A.L. Hepburn, J.C. Mason, and K.A. Davies Expression of Fcγ and complement receptors on peripheral blood monocytes in systemic lupus erythematosus and rheumatoid arthritis Rheumatology 43 2004 547 554
11. C. Hoyoux, J. Fodart, P. Rigo, P. Mahieu, and F. Geubelle Effects of methylprednisolone on the Fc-receptor function of human reticuloendothelial system in vivo Eur. J. Clin. Invest. 14 1984 60 66
12. B.M. Keegan, and J.H. Noseworthy Multiple sclerosis Annu. Rev. Med. 53 2002 285 302
13. R.P. Kimberly, J.E. Salmon, and J.C. Edberg Receptors for immunoglobulin G. Molecular diversity and implications for disease Arthritis Rheum. 38 1995 306 314
14. H. Lassmann, W. Brück, and C.F. Lucchinnetti Heterogenity of multiple sclerosis pathogenesis: implications for diagnosis and therapy Trends Mol. Med. 7 2001 115 121
15. C.F. Lucchinetti, W. Bruck, M. Rodriguez, and H. Lassmann Distinct patterns of multiple sclerosis pathology indicates heterogeneity on pathogenesis Brain Pathol. 6 1996 259 274
16. K.M. Myhr, G. Raknes, H. Nyland, and C. Vedeler Immunoglobulin G Fc-receptor (FcγR) IIA and IIIB polymorphisms related to disability in MS Neurology 52 1999 1771 1776
17. R. Newton Molecular mechanisms of glucocorticoid action: what is important? Thorax 55 2000 603 613
18. H. Nyland, S. Mørk, and R. Matre Fcγ receptors in multiple sclerosis brains Ann. N. Y. Acad. Sci. 436 1984 476 479
19. A.B. Rao, N. Richert, T. Howard, B.K. Lewis, C.N. Bash, H.F. McFarland, and J.A. Frank Methylprednisolone effect on brain volume and enhancing lesions in MS before and during IFNβ-1b Neurology 59 2002 688 694
20. M. Reindl, C. Linington, U. Brehm, R. Egg, E. Dilitz, F. Deisenhammer, W. Poewe, and T. Berger Antibodies against the myelin oligodendrocyte glycoprotein and the myelin basic protein in multiple sclerosis and other neurological diseases: a comparative study Brain 1222 1999 2047 2056
21. J.E. Salmon, S. Kapur, N.L. Meryhew, O.A. Runquist, and R.P. Kimberley High-dose, pulse intravenous methylprednisolone enhances Fc gamma receptor-mediated mononuclear phagocyte function in systemic lupus erythematosus Arthritis Rheum. 32 1989 717 725
22. W.A. Sibley, C.R. Bamford, and K. Clark Clinical viral infections and multiple sclerosis Lancet 1 1985 1313 1315
23. F.G.M. Snijdewint, M.L. Kapsenberg, P.J.J. Waubem-Penris, and J.D. Bos Corticosteroids class-dependently inhibit in vitro Th1-and Th2-type cytokine production Immunopharmacology 29 1995 93 101
24. R.W. Strickland, L.M. Wahl, and D.S. Finbloom Corticosteroids enhance the binding of recombinant interferon-γ to cultured human monocytes J. Immunol. 137 1986 1577 1580
25. I. Torsteinsdóttir, N.G. Arvidson, R. Hällgren, and L. Håkansson Monocyte activation in rheumatoid arthritis (RA): increased integrin, Fcγ and complement receptor expression and the effect of glucocorticoids Clin. Exp. Immunol. 115 1999 554 560
26. E. Ulvestad, K. Williams, C. Vedeler, J. Antel, H. Nyland, S. Mørk, and R. Matre Reactive microglia in multiple sclerosis lesions have an increased expression of receptors for the Fc part of IgG J. Neurol. Sci. 121 1994 125 131
27. W. Van der Pol, and J.G.J. Van de Winkel IgG receptor polymorphisms: risk factors for disease Immunogenetics 48 1998 222 232
28. C.A. Vedeler, K.M. Myhr, and H. Nyland Fc receptors for immunoglobulin G - a role in the pathogenesis of Guillain-Barré syndrome and multiple sclerosis J. Neuroimmunol. 118 2001 187 193
29. K.P. Wandinger, K. Wessel, P. Trillenberg, N. Heindl, and H. Kirchner Effect of high-dose methylprednisolone administration on immune function in multiple sclerosis patients Acta Neurol. Scand. 97 1998 359 365
30. H.Y. Wang, M. Matsui, S. Araya, N. Onai, K. Matsushima, and T. Saida Immune parameters associated with early treatment effects of high-dose intravenous methylprednisolone in multiple sclerosis J. Neurol. Sci. 216 2003 61 66
31. K.M. Warren, and S.N. Vogel Opposing effects of glucocorticoids on interferon-γ-induced murine macrophage Fc receptor and Ia antigen expression J. Immunol. 134 1985 2462 2469
32. B.G. Weinshenker, P.C. O'Brien, T.M. Petterson, J.H. Noseworthy, C.F. Lucchinetti, D.W. Dodick, A.A. Pineda, L.N. Stevens, and M. Rodriguez A randomized trial of plasma exchange in acute central nervous system inflammatory demyelinating disease Ann. Neurol. 46 1999 878 886